Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 GBX | 0.00% | +4.55% | +9.52% |
May. 31 | EARNINGS AND TRADING: CT UK High Income tops benchmark, ups dividend | AN |
Apr. 17 | Bivictrix granted FDA orphan drug status for rare cancer treatment | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.52% | 12.08M | |
+46.50% | 54.63B | |
-6.74% | 39.92B | |
+37.07% | 38.82B | |
+14.14% | 26.86B | |
-11.17% | 26.22B | |
-21.87% | 18.78B | |
+25.87% | 12.21B | |
+0.75% | 12.16B | |
+26.62% | 11.94B |
- Stock Market
- Equities
- BVX Stock
- News BiVictriX Therapeutics Plc
- BiVictriX Therapeutics Secures US Patent for Lead Asset